Clinical Trial Update: Master Framework For Relapse or Refractory Acute Myeloid Leukemia

View source ↗

Summary

A clinical trial update describes a master framework for relapse or refractory acute myeloid leukemia and notes that the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory | Status: RECRUITING